Nephrocare Health Services Ltd Board Approves Financial Results and Restructuring
Nephrocare Health Services Ltd announced the outcome of its Board meeting held on August 11, 2026. The Board approved the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the Limited Review Report. Additionally, the Board approved the reconstitution of the Audit Committee and the Stakeholders Relationship Committee, effective August 17, 2026. A significant decision was the approval of the proposed transfer of 51% shareholding in Nephrocare Health Services Saudi Arabia Company from Nephrocare Health Services International Pte. Ltd. to NephroPlus Kidney Services Company as part of an internal group restructuring. The consideration for this transfer is Saudi Riyal 2.24 million.
Key Highlights
- Board approved Q1 FY27 unaudited standalone & consolidated financial results.
- Audit Committee and Stakeholders Relationship Committee reconstituted.
- Internal restructuring involves transfer of Saudi Arabia subsidiary shares.
- Transfer of 51% stake in NHSSAC for SAR 2.24 million.
- No change in ultimate beneficial ownership of NHSSAC.
Price Impact
More from NEPHROPLUS